[1] Siegel RL, Miller KD, Jemal A.Cancer statistics, 2020[J]. CA Cancer J Clin, 2020,70(1):7-30. [2] Ma Y, Shepherd J, Zhao D, et al.SOX9 Is Essential for Triple-Negative Breast Cancer Cell Survival and Metastasis[J]. Mol Cancer Res, 2020,18(12):1825-1838. [3] Li J, Huo X, Zhao F, et al.Association of Cyclin-Dependent Kinases 4 and 6 Inhibitors With Survival in Patients With Hormone Receptor-Positive Metastatic Breast Cancer: A Systematic Review and Meta-analysis[J]. JAMA Netw Open, 2020,3(10):e2020312. [4] Sim WJ, Iyengar PV, Lama D, et al.c-Met activation leads to the establishment of a TGFbeta-receptor regulatory network in bladder cancer progression[J]. Nat Commun, 2019,10(1):4349. [5] Dongre A, Rashidian M, Eaton EN, et al.Direct and Indirect Regulators of Epithelial-Mesenchymal Transition (EMT)-mediated Immunosuppression in Breast Carcinomas[J]. Cancer Discov, 2021,11(5):1286-1305. [6] Su S, Liu Q, Chen J, et al.A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis[J]. Cancer Cell, 2014,25(5):605-620. [7] Navas T, Kinders RJ, Lawrence SM, et al.Clinical Evolution of Epithelial-Mesenchymal Transition in Human Carcinomas[J]. Cancer Res, 2020,80(2):304-318. [8] Wang Z, Li Z, Wu Q, et al.DNER promotes epithelial-mesenchymal transition and prevents chemosensitivity through the Wnt/beta-catenin pathway in breast cancer[J]. Cell Death Dis, 2020,11(8):642. [9] Zhao B, Liu L, Mao J, et al.PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis[J]. Cell Death Dis, 2018,9(3):307. [10] Wu W, Chen F, Cui X, et al.LncRNA NKILA suppresses TGF-beta-induced epithelial-mesenchymal transition by blocking NF-kappaB signaling in breast cancer[J]. Int J Cancer, 2018,143(9):2213-2224. [11] Li GY, Wang W, Sun JY, et al.Long non-coding RNAs AC026904.1 and UCA1: a “one-two punch” for TGF-beta-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer[J]. Theranostics, 2018,8(10):2846-2861. [12] Mondal T, Subhash S, Vaid R, et al.MEG3 long noncoding RNA regulates the TGF-beta pathway genes through formation of RNA-DNA triplex structures[J]. Nat Commun, 2015,6:7743. [13] Statello L, Guo CJ, Chen LL, et al.Gene regulation by long non-coding RNAs and its biological functions[J]. Nat Rev Mol Cell Biol, 2021, 22(2): 96-118. [14] Suwakulsiri W, Chen M, Greening DW, et al.Analysis of Annotated and Unannotated Long Noncoding RNAs from Exosome Subtypes Using Next-Generation RNA Sequencing[J]. Methods Mol Biol, 2021,2254:195-218. [15] Wang X, Hu X, Song W, et al.Mutual dependency between lncRNA LETN and protein NPM1 in controlling the nucleolar structure and functions sustaining cell proliferation[J]. Cell Res, 2021. doi: 10.1038/s41422-020-00458-6 [16] Hu JJ, Zhou C, Luo X, et al.Linc-SCRG1 accelerates progression of hepatocellular carcinoma as a ceRNA of miR26a to derepress SKP2[J]. J Exp Clin Cancer Res, 2021,40(1):26. [17] Guo B, Wu S, Zhu X, et al.Micropeptide CIP2A-BP encoded by LINC00665 inhibits triple-negative breast cancer progression[J]. EMBO J, 2020,39(1):e102190. [18] Wang P, Chen W, Ma T, et al.lncRNA lnc-TSI Inhibits Metastasis of Clear Cell Renal Cell Carcinoma by Suppressing TGF-beta-Induced Epithelial-Mesenchymal Transition[J]. Mol Ther Nucleic Acids, 2020,22:1-16. [19] Wang P, Luo ML, Song E, et al.Long noncoding RNA lnc-TSI inhibits renal fibrogenesis by negatively regulating the TGF-beta/Smad3 pathway[J]. Sci Transl Med, 2018,10(462). [20] Xu J, Lamouille S, Derynck R.TGF-beta-induced epithelial to mesenchymal transition[J]. Cell Res, 2009,19(2):156-172. [21] Hao Y, Baker D, Ten DP.TGF-beta-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis[J]. Int J Mol Sci, 2019,20(11): 2767. |